Anti-colitis and -adhesion effects of daikenchuto via endogenous adrenomedullin enhancement in Crohn's disease mouse model

Kitamura, 1993, Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma, Biochem Biophys Res Commun, 192, 553, 10.1006/bbrc.1993.1451 Wu, 2003, Adrenomedullin and adrenomedullin binding protein-1 downregulate TNF-alpha in macrophage cell line and rat Kupffer cells, Regul Pept, 112, 19, 10.1016/S0167-0115(03)00018-1 Sandborn, 2007, Clinical perspectives in Crohn's disease. Moving forward with anti-TNF-alpha therapy: current needs and future treatments, Rev Gastroenterol Disord, 7, S23 Gonzalez-Rey, 2006, Therapeutic effect of urocortin and adrenomedullin in a murine model of Crohn's disease, Gut, 55, 824, 10.1136/gut.2005.084525 Talero, 2008, Acute and chronic responses associated with adrenomedullin administration in experimental colitis, Peptides, 29, 2001, 10.1016/j.peptides.2008.07.013 Eto, 1999, Biological and clinical roles of adrenomedullin in circulation control and cardiovascular diseases, Clin Exp Pharmacol Physiol, 26, 371, 10.1046/j.1440-1681.1999.03047.x Meeran, 1997, Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study, J Clin Endocrinol Metab, 82, 95, 10.1210/jc.82.1.95 Westphal, 2004, Adrenomedullin: a smart road from pheochromocytoma to treatment of pulmonary hypertension, Eur Respir J, 24, 518, 10.1183/09031936.04.10060404 Kono, 2009, Exodus of Kampo, traditional Japanese medicine, from the complementary and alternative medicines: is it time yet?, Surgery, 146, 837, 10.1016/j.surg.2009.06.012 Endo, 2006, Dai-kenchu-to, a Chinese herbal medicine, improves stasis of patients with total gastrectomy and jejunal pouch interposition, Am J Surg, 192, 9, 10.1016/j.amjsurg.2006.01.022 Itoh, 2002, The effect of the herbal medicine dai-kenchu-to on post-operative ileus, J Int Med Res, 30, 428, 10.1177/147323000203000410 Iwai, 2007, Effects of herbal medicine Dai-Kenchu-to on anorectal function in children with severe constipation, Eur J Pediatr Surg, 17, 115, 10.1055/s-2007-965016 Suehiro, 2005, The effect of the herbal medicines dai-kenchu-to and keishi-bukuryo-gan on bowel movement after colorectal surgery, Hepatogastroenterology, 52, 97 Tokita, 2007, The pharmacological effects of Daikenchuto, a traditional herbal medicine, on delayed gastrointestinal transit in rat postoperative ileus, J Pharmacol Sci, 104, 303, 10.1254/jphs.FP0070831 Fukuda, 2006, The herbal medicine, Dai-Kenchu-to, accelerates delayed gastrointestinal transit after the operation in rats, J Surg Res, 131, 290, 10.1016/j.jss.2005.09.018 Satoh, 2003, Effect of Dai-kenchu-to (Da-Jian-Zhong-Tang) on the delayed intestinal propulsion induced by chlorpromazine in mice, J Ethnopharmacol, 86, 37, 10.1016/S0378-8741(03)00038-2 Satoh, 2001, Mechanism of atropine-resistant contraction induced by Dai-kenchu-to in guinea pig ileum, Jpn J Pharmacol, 86, 32, 10.1254/jjp.86.32 Satoh, 2001, Mechanisms for contractile effect of Dai-kenchu-to in isolated guinea pig ileum, Dig Dis Sci, 46, 250, 10.1023/A:1005636412287 Tokita, 2007, The preventive effect of Daikenchuto on postoperative adhesion-induced intestinal obstruction in rats, Inflammopharmacology, 15, 65, 10.1007/s10787-006-1552-2 Hayakawa, 1999, Effects of Dai-kenchu-to on intestinal obstruction following laparotomy, J Smooth Muscle Res, 35, 47, 10.1540/jsmr.35.47 Murata, 2002, The herbal medicine Dai-kenchu-to and one of its active components [6]-shogaol increase intestinal blood flow in rats, Life Sci, 70, 2061, 10.1016/S0024-3205(01)01552-1 Kono, 2008, Colonic vascular conductance increased by Daikenchuto via calcitonin gene-related peptide and receptor-activity modifying protein 1, J Surg Res, 150, 78, 10.1016/j.jss.2008.02.057 Hay, 2003, CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22–52, CGRP8-37 and BIBN4096BS, Br J Pharmacol, 140, 477, 10.1038/sj.bjp.0705472 Xia, 2006, Postischemic infusion of adrenomedullin protects against ischemic stroke by inhibiting apoptosis and promoting angiogenesis, Exp Neurol, 197, 521, 10.1016/j.expneurol.2005.10.027 Eysselein, 1992, Calcitonin gene-related peptide in inflammatory bowel disease and experimentally induced colitis, Ann N Y Acad Sci, 657, 319, 10.1111/j.1749-6632.1992.tb22779.x Mazelin, 1999, Vagally dependent protective action of calcitonin gene-related peptide on colitis, Peptides, 20, 1367, 10.1016/S0196-9781(99)00144-8 Reinshagen, 1998, Calcitonin gene-related peptide mediates the protective effect of sensory nerves in a model of colonic injury, J Pharmacol Exp Ther, 286, 657 Reinshagen, 1996, Action of sensory neurons in an experimental at colitis model of injury and repair, Am J Physiol, 270, G79 Kawada, 2007, Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease, World J Gastroenterol, 13, 5581, 10.3748/wjg.v13.i42.5581 Appleyard, 1995, Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs, Am J Physiol, 269, G119 Zhu, 2008, Immunization with adenovirus at the large intestinal mucosa as an effective vaccination strategy against sexually transmitted viral infection, Mucosal Immunology, 1, 78, 10.1038/mi.2007.3 Allaker, 2003, Adrenomedullin and mucosal defence: interaction between host and microorganism, Regul Pept, 112, 147, 10.1016/S0167-0115(03)00033-8 Marutsuka, 2001, Adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP) are present in human colonic epithelia and exert an antimicrobial effect, Exp Physiol, 86, 543, 10.1113/eph8602250 Clavel, 2007, Bacteria- and host-derived mechanisms to control intestinal epithelial cell homeostasis: implications for chronic inflammation, Inflamm Bowel Dis, 13, 1153, 10.1002/ibd.20174 Minamino, 2002, Regulation of adrenomedullin expression and release, Microsc Res Tech, 57, 28, 10.1002/jemt.10048 Miksa, 2007, Vasoactive hormone adrenomedullin and its binding protein: anti-inflammatory effects by up-regulating peroxisome proliferator-activated receptor-gamma, J Immunol, 179, 6263, 10.4049/jimmunol.179.9.6263 Takei, 2004, Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator, FEBS Lett, 556, 53, 10.1016/S0014-5793(03)01368-1 Lin Chang, 2005, Intermedin functions as a pituitary paracrine factor regulating prolactin release, Mol Endocrinol, 19, 2824, 10.1210/me.2004-0191 Ghosh, 2006, Interfering with interferons in inflammatory bowel disease, Gut, 55, 1071, 10.1136/gut.2005.090134 Reinisch, 2006, A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's disease, Gut, 55, 1138, 10.1136/gut.2005.079434 Hommes, 2006, Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease, Gut, 55, 1131, 10.1136/gut.2005.079392 Kosaka, 2008, Interferon-gamma is a therapeutic target molecule for prevention of postoperative adhesion formation, Nat Med, 14, 437, 10.1038/nm1733 Ohya, 2003, Effect of dai-kenchu-to on obstructive bowel disease in children, Am J Chin Med, 31, 129, 10.1142/S0192415X03000710